Target intelligence / Profile preview

Cell Membranes and Lipid Metabolic Pathways

Molecular classification
Other
01

Overview

Cell membranes and lipid metabolic pathways represent the structural framework and the complex network of biochemical reactions involved in the synthesis, transport, and degradation of lipids. Cell membranes are primarily composed of phospholipid bilayers, cholesterol, and sphingolipids, which are essential for maintaining cellular integrity and facilitating signal transduction (Alberts et al., 2002, Molecular Biology of the Cell). Lipid metabolic pathways, such as the mevalonate pathway and fatty acid oxidation, regulate the homeostasis of these molecules to provide energy and precursors for signaling (Ahmed et al., 2023, StatPearls). Dysregulation within these pathways is a primary driver of metabolic diseases, including atherosclerosis and type 2 diabetes, and is increasingly recognized as a hallmark of cancer progression (Kopecka et al., 2020, Nature Reviews Cancer). Although this entry describes a broad biological system rather than a single protein, it contains numerous validated therapeutic targets like HMG-CoA reductase and PCSK9. Drugs targeting these specific components, such as statins and monoclonal antibodies, work by modulating lipid levels to reduce cardiovascular risk (Mach et al., 2020, European Heart Journal). Understanding the interplay between membrane composition and metabolic flux is crucial for developing next-generation therapies for metabolic and oncological disorders.

Other names
Lipid metabolismMembrane lipid homeostasisLipid signaling pathwaysCellular lipidome
02

Mechanism of action

Pharmacological intervention occurs through the inhibition of specific biosynthetic enzymes, activation of nuclear receptors, or modulation of lipid transport proteins within the broader metabolic network.

03

Biological functions

Lipid synthesisLipid degradationMembrane structural integritySignal transductionEnergy storageVesicular transport
04

Disease associations

Cardiovascular diseaseDyslipidemiaMetabolic syndromeCancerNeurodegenerative diseaseObesity
05

Safety considerations

MyopathyHepatotoxicityGastrointestinal distressPotential disruption of steroid hormone synthesis
06

Interacting drugs

Atorvastatin

4 more in the full profile.

07

Biomarkers

Low-density lipoprotein cholesterol (LDL-C)High-density lipoprotein cholesterol (HDL-C)TriglyceridesApolipoprotein B

Beyond the preview

Go deeper on Cell Membranes and Lipid Metabolic Pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell Membranes and Lipid Metabolic Pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call